Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGHE.L Regulatory News (GHE)

  • There is currently no data for GHE

Form 8.3 - Gresham House plc

27 Nov 2023 12:12

RNS Number : 7919U
Barclays PLC
27 November 2023

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR

MORE

Rule 8.3 of the Takeover Code (the "Code")

1.

KEY INFORMATION

(a)

Full name of discloser:

Barclays PLC.

(b)

Owner or controller of interest and short

positions disclosed, if different from 1(a):

(c)

Name of offeror/offeree in relation to whose

GRESHAM HOUSE PLC

relevant securities this form relates:

(d)

If an exempt fund manager connected with an

offeror/offeree, state this and specify identity of

offeror/offeree:

(e)

Date position held/dealing undertaken:

24 Nov 2023

(f)

In addition to the company in 1(c) above, is the discloser making

NO

disclosures in respect of any other party to the offer?

2.

POSITIONS OF THE PERSON MAKING THE DISCLOSURE

(a)

Interests and short positions in the relevant securities of the offeror or offeree

to which the disclosure relates following the dealing(if any)

Class of relevant security:

25p ordinary

Interests

Short Positions

Number

(%)

Number

(%)

(1)

Relevant securities owned

and/or controlled:

1,262,689

3.30%

0

0.00%

(2)

Cash-settled derivatives:

and/or controlled:

0

0.00%

1,307,377

3.42%

(3)

Stock-settled derivatives (including options)

and agreements to purchase/sell:

0

0.00%

0

0.00%

TOTAL:

1,262,689

3.30%

1,307,377

3.42%

(b)

Rights to subscribe for new securities (including directors and other executive

options)

Class of relevant security in relation to

which subscription right exists

Details, including nature of the rights

concerned and relevant percentages:

3.

DEALINGS (IF ANY) BY THE EXEMPT PRINCIPAL TRADER

(a)

Purchases and sales

Class of relevant

Purchase/sale

Number of

Price per unit

security

securities

25p ordinary

Sale

439

10.9550 GBP

(b)

Cash-settled derivative transactions

Class of

Product

Nature of dealing

Number of

Price per

relevant

description

reference

unit

security

securities

25p ordinary

SWAP

Long

439

10.9538 GBP

(c)

Stock-settled derivative transactions (including options)

(i)

Writing, selling, purchasing or varying

Class

Product

Writing,

Number

Exercise

Type

Expiry

Option

of

description

purchasing,

of

price

date

money

relevant

selling,

securities

per unit

paid/

security

varying etc

to which

received

option

per unit

relates

(ii)

Exercising

Class of relevant

Product description

Exercising/ exercised against

Number of

Exercise price per

security

securities

unit

(d)

Other dealings (including subscribing for new securities)

Class of relevant

Nature of Dealings

Details

Price per unit (if

security

applicable)

4.

OTHER INFORMATION

(a)

Indemnity and other dealings arrangements

Details of any indemnity or option arrangement, or any agreement or understanding,

formal or informal, relating to relevant securities which may be an inducement to deal

or refrain from dealing entered into by the exempt principal trader making the disclosure and any party

to the offer or any person acting in concert with a party to the offer:

NONE

(b)

Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between

the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights of future acquisition or disposal of any relevant securities to which

any derivative is referenced:

NONE

(c)

Attachments

Is a Supplemental Form 8 (Open Positions) attached?

NO

Date of disclosure:

27 Nov 2023

Contact name:

Large Holdings Regulatory Operations

Telephone number:

020 3134 7213

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
RETBRBTTMTMTBFJ
Date   Source Headline
24th Apr 20233:27 pmRNSEBT Share Purchase
20th Apr 20237:00 amRNSProgress Update
14th Apr 20237:00 amRNSPosting of Report and Accounts and Notice of AGM
11th Apr 20235:31 pmRNSEBT Share Purchase
3rd Apr 20235:47 pmRNSEBT Share Purchase
31st Mar 20238:19 amRNSDirector/PDMR Shareholding
30th Mar 20237:00 amRNSAnnual Results for the year ended 31 December 2022
21st Mar 20232:11 pmRNS2022 Annual Results - revised publication date
15th Mar 20237:00 amRNSNotice of Results
20th Feb 20232:47 pmRNSEBT Share Purchase
13th Feb 20233:06 pmRNSEBT Share Purchase
6th Feb 20235:42 pmRNSEBT Share Purchase
30th Jan 20233:17 pmRNSEBT Share Purchase
25th Jan 20237:00 amRNSPre-Close Update
23rd Jan 20233:03 pmRNSEBT Share Purchase
20th Jan 20237:00 amRNSProgress Update
16th Jan 20234:50 pmRNSEBT Share Purchase
9th Jan 20232:16 pmRNSEBT Share Purchase
9th Jan 20237:00 amRNSLaunch of Irish forestry fund
29th Dec 20229:16 amRNSEBT Share Purchase
23rd Dec 20228:51 amRNSDirector/PDMR Shareholding
22nd Dec 20227:00 amRNSProgress Update
21st Dec 20222:46 pmRNSIncreased Purchase of Shares by EBT
19th Dec 20223:06 pmRNSEBT Share Purchase
12th Dec 20222:11 pmRNSEBT Share Purchase
29th Nov 20229:31 amRNSEBT Share Purchase
22nd Nov 20229:47 amRNSEBT Share Purchase
22nd Nov 20228:56 amRNSDirector/PDMR Shareholding
15th Nov 20227:00 amRNSDirector/PDMR Shareholding
10th Nov 20224:03 pmRNSDirector/PDMR Shareholding
9th Nov 20227:00 amRNSTrading Update and Capital Markets Day
7th Nov 20222:41 pmRNSEBT Share Purchase
17th Oct 20225:07 pmRNSEBT Share Purchase
10th Oct 20224:21 pmRNSEBT Share Purchase
3rd Oct 20226:13 pmRNSEBT Share Purchase
21st Sep 20222:48 pmRNSVesting of 2018 Performance Share Plan awards
15th Sep 20227:00 amRNSInterim results
12th Sep 20224:02 pmRNSEBT Share Purchase
12th Sep 20222:47 pmRNSDirector/PDMR Shareholding
5th Sep 20224:01 pmRNSEBT Share Purchase
31st Aug 20227:00 amRNSNotice of Interim Results
30th Aug 20225:34 pmRNSEBT Share Purchase
22nd Aug 20223:47 pmRNSEBT Share Purchase
16th Aug 20227:00 amRNSEBT Share Purchase
1st Aug 20221:44 pmRNSEBT Share Purchase
25th Jul 20223:05 pmRNSEBT Share Purchase
14th Jul 202212:02 pmRNSIntended Purchase of Shares by EBT
13th Jul 20227:00 amRNSTrading Statement
15th Jun 20222:13 pmRNSNotification of Major Holdings
1st Jun 20227:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.